Literature DB >> 21841771

Pancreatic-type acinar cell carcinoma of the liver: a clinicopathologic study of four patients.

Abbas Agaimy1, Annette Kaiser, Karen Becker, Jan-Hinrich Bräsen, Peter H Wünsch, N Volkan Adsay, Günter Klöppel.   

Abstract

Acinar cell carcinoma of pancreatic type rarely occurs at extra-pancreatic sites. We report four primary liver tumors with features of pancreatic acinar cell carcinoma. The patients were two males and two females with a mean age of 65 years (range, 49-72 years). They had upper abdominal pain, weight loss and/or an incidentally discovered liver mass. None had evidence of a primary pancreatic tumor. Grossly, the tumors were large (mean size, 12 cm), well circumscribed and showed a lobulated cut surface. Histologically, they showed a predominantly microacinar pattern, with occasional trabecular, solid and microcystic areas. Cellular atypia and mitotic activity varied within the same tumor and from tumor to tumor. Immunohistochemically, the tumor cells were positive for cytokeratin 18 and at least one acinar cell marker (ie, trypsin, amylase or lipase), but were negative for cytokeratins 7, 19 and 20, HepPar-1, AFP, CD10, carcinoembryonic antigen, CD56, Islet-1 and CDX2. Two tumors stained focally for synaptophysin and chromogranin A. Adjacent liver parenchyma displayed no evidence of cirrhosis. During a mean follow-up of 22 months (range, 3-38 months) no metastases occurred, but one patient developed local recurrence. Our study demonstrates that acinar cell carcinoma of pancreatic type may also originate from the liver and can be readily distinguished from other primary liver neoplasms by its distinct histological and immunohistochemical features. Because our cases were observed within a rather short period, it is likely that this tumor type is so far underrecognized and has been mistaken as a variant of hepatocellular carcinoma, cholangiocarcinoma or any other liver tumor.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21841771     DOI: 10.1038/modpathol.2011.127

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  10 in total

1.  Hepatobiliary and Pancreatic: Primary acinar cell carcinoma of the liver showing good response to chemotherapy.

Authors:  M E Laino; M Ragucci; D S Klimstra; L Mannelli
Journal:  J Gastroenterol Hepatol       Date:  2018-05       Impact factor: 4.029

2.  Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy.

Authors:  Emmet J Jordan; Olca Basturk; Jinru Shia; David S Klimstra; William Alago; Michael I D'Angelica; Ghassan K Abou-Alfa; Eileen M O'Reilly; Maeve A Lowery
Journal:  J Gastrointest Oncol       Date:  2017-10

3.  A FISH assay efficiently screens for BRAF gene rearrangements in pancreatic acinar-type neoplasms.

Authors:  Lu Wang; Olca Basturk; Jiajing Wang; Ryma Benayed; Sumit Middha; Ahmet Zehir; Irina Linkov; Mamta Rao; Ruth Aryeequaye; Long Cao; Juliann Chmielecki; Jeffrey Ross; Philip J Stephens; Volkan Adsay; Gokce Askan; Serdar Balci; David S Klimstra
Journal:  Mod Pathol       Date:  2017-09-08       Impact factor: 7.842

Review 4.  Acinar Cell Carcinoma of the Pancreas: Overview of Clinicopathologic Features and Insights into the Molecular Pathology.

Authors:  Stefano La Rosa; Fausto Sessa; Carlo Capella
Journal:  Front Med (Lausanne)       Date:  2015-06-15

Review 5.  Pancreatic panniculitis in a patient with pancreatic-type acinar cell carcinoma of the liver--case report and review of literature.

Authors:  Sebastian Zundler; Ramona Erber; Abbas Agaimy; Arndt Hartmann; Franklin Kiesewetter; Deike Strobel; Markus F Neurath; Dane Wildner
Journal:  BMC Cancer       Date:  2016-02-20       Impact factor: 4.430

6.  Primary extra-pancreatic pancreatic-type acinar cell carcinoma in the right perinephric space: A case report and review of literature.

Authors:  Yi-Yuan Wei; Ying Li; Yan-Jie Shi; Xiao-Ting Li; Ying-Shi Sun
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

7.  Acinar cell carcinoma of the pancreas: clinical and cytomorphologic characteristics.

Authors:  Adam D Toll; Ralph H Hruban; Syed Z Ali
Journal:  Korean J Pathol       Date:  2013-04-24

8.  First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case report.

Authors:  Carla B Ripamonti; Mara Colombo; Patrizia Mondini; Manoukian Siranoush; Bernard Peissel; Loris Bernard; Paolo Radice; Maria Luisa Carcangiu
Journal:  BMC Cancer       Date:  2013-02-01       Impact factor: 4.430

9.  Cytopathology and ultrastructure identification of primary hepatic acinar cell carcinoma: Case report.

Authors:  J G Grab; D Skubleny; N M Kneteman
Journal:  Int J Surg Case Rep       Date:  2019-08-17

10.  Successful BRAF/MEK inhibition in a patient with BRAF V600E-mutated extrapancreatic acinar cell carcinoma.

Authors:  Elena Busch; Simon Kreutzfeldt; Abbas Agaimy; Gunhild Mechtersheimer; Peter Horak; Benedikt Brors; Barbara Hutter; Martina Fröhlich; Sebastian Uhrig; Philipp Mayer; Evelin Schröck; Albrecht Stenzinger; Hanno Glimm; Dirk Jäger; Christoph Springfeld; Stefan Fröhling; Stefanie Zschäbitz
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-08-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.